Greater Cincinnati public company inks six-figure deal as merger looms

medical-research-and-pharmaceutical-research

A Greater Cincinnati public company in the midst of a merger with a California-based competitor is selling some of its top intellectual property to the tune of nearly $500,000.

Aerpio Pharmaceuticals (Nasdaq: ARPO), a Blue Ash-based biopharma company, entered into an asset purchase agreement earlier this month with EyePoint Pharmaceuticals, headquartered in Watertown, Mass., per a Securities and Exchange Commission filing.

Click here to read the complete story.

Story excerpt provided by Cincinnati Business Courier.

Written by Liz Engel.

Originally published August 25, 2021.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: